Skip to content
Home/Companies/Biotech/TRexBio
TRexBio

TRexBio

Biotech·United States·Active·8yr hold
Entry
2018
Hold
8yr
Status
Active

Who owns TRexBio?

TRexBio is currently owned by SV Health Managers through SV Life Sciences Fund VI (2015 vintage), since 2018.

Hand-verified · updated 2026-07-16

SV Health Managers
Investor
SV Health Managers
SV Life Sciences Fund VI · 2015 · Life Sciences VC

Key facts

HQUnited States
SectorBiotech
StatusActive
Websitetrex.bio

More from SV Life Sciences Fund VI

Other portfolio companies in the same fund.

Sitryx Therapeutics
Sitryx Therapeutics
Active
BiotechUK· 2018
Artios Pharma
Artios Pharma
Active
BiotechUK· 2016

More SV Health Managers portfolio companies

From the same investor, across funds.

AdvanCell
Active
BiotechAustralia· 2025
Draig Therapeutics
Draig Therapeutics
Active
BiotechUK· 2025
Leal Therapeutics
Active
BiotechUnited States· 2025
Brixton Biosciences
Brixton Biosciences
Active
MedTechUnited States· 2024
Montara Therapeutics
Active
BiotechUnited States· 2024
CarePredict
Active
HealthTechUnited States· 2023

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
GenSight Biologics
GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Healx
Active
Amadeus Capital PartnersUK
Track TRexBio

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on TRexBio.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue